Teva Invalidates Opiant Patents In Narcan Suit
A New Jersey federal judge found that claims from four patents related to Narcan, the nasal spray treatment for opioid overdoses, are invalid Friday, handing a win to Teva Pharmaceuticals USA...To view the full article, register now.
Already a subscriber? Click here to view full article